What Does 2024 Hold For Biopharma? Treehill Partners featured in Scrip
Treehill Partners featured amongst prominent KOLs in Part 2 of Scrip’s 2024 biopharma outlook interview, discussing funding environment, M&A, and partnering. Read the article on Scrip: https://scrip.citeline.com/SC149635/Scrip-AsksWhat-Does-2024-Hold-For-Biopharma-Part-2-The-Funding-Environment-MA-And-Partnering